Kovo HealthTech Corporation provided earnings guidance for the full year 2022. The company is on-track to meet the anticipated 30% organic growth target (exclusive of acquisitions) outlined in its initial 2022 guidance released earlier this year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | 0.00% | 0.00% | -16.67% |
1st Jan change | Capi. | |
---|---|---|
-16.67% | 1.05M | |
+5.91% | 32.95B | |
+18.17% | 8.01B | |
+33.03% | 4.38B | |
-29.52% | 2.67B | |
-13.29% | 1.5B | |
-28.02% | 1.27B | |
-33.09% | 1.2B | |
+11.35% | 996M | |
-38.47% | 864M |
- Stock Market
- Equities
- KOVO Stock
- News Kovo HealthTech Corporation
- Kovo HealthTech Corporation Provides Earnings Guidance for the Full Year 2022